Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
Clinical trial NCT01709513 · COMPLETED
Trial details
- NCT number
- NCT01709513
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-30
- Primary completion
- 2014-05-31
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.